Role of proteinuria in defining pre-eclampsia: Clinical outcomes for women and babies

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 4, 2010, Pages 466-470

  Thornton, Charlene E ^a   Makris, Angela ^b   Ogle, Robert F ^c   Tooher, Jane M ^c   Hennessy, Annemarie ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Epidemiology; Hypertension; Pre eclampsia; Pregnancy; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECLAMPSIA; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; OUTCOME ASSESSMENT; PERINATAL MORTALITY; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PRENATAL PERIOD; PROTEINURIA; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; COHORT STUDIES; DISEASE PROGRESSION; ECLAMPSIA; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; KIDNEY FAILURE, ACUTE; MAGNESIUM SULFATE; MALE; MATERNAL MORTALITY; MEDICAL RECORDS; PERINATAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROTEINURIA; PULMONARY EDEMA; RETROSPECTIVE STUDIES;

EID: 77949881589     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05334.x     Document Type: Article

References (25)

1. Thornton C, Hennessy A, von Dadelszen P, Nishi C, Makris A, Ogle R. An international benchmarking collaboration: Measuring outcomes for the hypertensive disorders of pregnancy. J. Obstet. Gynaecol. Can. 2007 29 : 794 800.
2. Centre for Epidemiology and Research. NSW Department of Health. New South Wales. Mothers and Babies 2005. NSW Health Bull. 2007 18 : 27 8.
3. Hoyert DL, Johannson LA, Rosenberg HM, World Health Organization Mortality Reference Group. Annual Report, 2001-2002. World Health Organization, Geneva, 2003.
4. Brown MA, Hague WM, Higgins J et al. The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust. NZ J. Obstet. Gynaecol. 2000 40 : 133 138.
5. Brown M, Lindheimer M, de Swiet M et al. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy. Hypertens. Pregnancy 2001 20 : IX XIV.
6. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000 183 (Suppl. S1 22.
7. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Concensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Can. Med. Assoc. J. 1997 157 : 715 725.
8. Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet 2001 357 : 131 135.
9. Phelan LK, Brown MA, Davis GK, Mangos G. A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia. Hypertens. Pregnancy 2004 23 : 135 142.
10. The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM). National Centre for Classification in Health, Sydney. 2002.
11. Beeby PJ, Bhuta T, Taylor LK. NSW population-based birth-weight percentile charts. J Paed Child Health. 1996 32 : 512 518.
12. Schulz KF, Grimes DA. Multiplicity in randomised trials I. Endpoints and treatments. Lancet 2005 365 : 1591 1595.
13. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev. 2007 1 : CD002252.
14. Belizan JM, Althabe F, Cafferata ML. Health consequences of the increasing Caesarean section rates. Epidemiology 2007 18 : 485 486.
15. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Evidence from randomized trials. Clin. Obstet. Gynecol. 2005 48 : 478 488.
16. Duley L, Farrell B, Moodley J, Neilson J, Smith D, Magpie Trial Collaboration Group. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebocontrolled trial. Lancet 2002 359 : 1877 1890.
17. Zanardo V, Simbi AK, Franzoi M, Solda G, Salvadori A, Trevisanuto D. Neonatal respiratory morbidity risk and mode of delivery at term: Influence of elective Caesarean delivery. Acta Paediatr. 2004 93 : 643 647.
18. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for HELLP syndrome. Am. J. Obstet. Gynecol. 1996 175 : 460 464.
19. Martin JN Jr., Rinehart B, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia comparative analysis by HELLP syndrome classification. Am. J. Obstet. Gynecol. 1999 180 : 1373 1384.
20. Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pregnancy: How much matters? Br. J. Obstet. Gynaecol. 2005 112 : 280 285.
21. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauh J, Lindheimer MD. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild-preeclampsia. Am. J. Obstet. Gynecol. 2002 186 : 66 71.
22. Zhang J, Klebanoff MA, Robetrs JM. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet. Gynecol. 2001 97 : 261 267.
23. Brown MA, Buddle ML. What's in a name? Problems with the classification of hypertension in pregnancy. J. Hypertens. 1997 15 : 1049 1054.
24. Homer CSE, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: A novel risk indicator in women with gestational hypertension. J. Hypertens. 2007 26 : 295 302.
25. North R, Taylor R, Schellenberg JC. Evaluation of a definition of pre-eclampsia. Br. J. Obstet. Gynaecol. 1999 106 : 767 773.